Summary.-Viable cultured oat-cell carcinoma cells were used to immunize a goat. The resulting antiserum contained high titres of anti-normal activity and antibodies to CEA. It was also shown, by indirect immunofluorescence, using fluoresceinconjugated rabbit anti-goat Ig, to localize at high titres on the surface membranes of human lung cancer cells of 4 different histological types. Booster immunizations produced a maximum secondary response one week after 2 weekly injections.
Summary.-Viable cultured oat-cell carcinoma cells were used to immunize a goat. The resulting antiserum contained high titres of anti-normal activity and antibodies to CEA. It was also shown, by indirect immunofluorescence, using fluoresceinconjugated rabbit anti-goat Ig, to localize at high titres on the surface membranes of human lung cancer cells of 4 different histological types. Booster immunizations produced a maximum secondary response one week after 2 weekly injections.
The course of each immunization has been monitored for activity against normal human tissues, and the final sera have been absorbed with human spleen cells to remove anti-normal activity. Cross-reactivity with the lung-cancer-cell panel and antibodies to CEA persisted in high titre after absorption of anti-normal antibodies, and were present in the ammonium-sulphate-precipitated globulin fraction.
The cells used for immunization did not produce detectable amounts of CEA in culture, and were not known to contain CEA prior to this experiment. Removal of anti-CEA antibodies by absorption with purified CEA has not reduced the crossreactivity of the absorbed antiserum with the panel of human lung-cancer cells.
HUMAN lung tumours produce tumourassociated macromolecules which can be identified in patients' sera (Vincent and Chu, 1973) and which, in some individuals, are valuable as serum markers indicating disease status (Newman et al., 1976; Ford, Newman and Lakin, 1977) . Derepressed gene products of tumour cells (e.g. differentiation antigens, hormones and foetal proteins) are unlikely to be immunogenic in the human tumour-bearing host, who will have already developed immunological tolerance of them during foetal life. Other tumour-associated antigens not detected during foetal development have also been described (Hollinshead and Stewart, 1977) .
Xenoantisera contain antibodies to lungtumour antigens as well as to "normal" antigens (Viza et al., 1975; Frost, Rogers and Bagshawe, 1975; Bell and Seetharam, 1976; Newman et al., 1977b) . These antisera, after removal of anti-normal antibodies by absorption with normal-tissue preparations, can be used to identify tumour antigens, and in therapeutic attempts to improve the poor prognosis in advanced malignant melanoma (Everall et al., 1977) and after resection of lung cancer (Newman et al., 1977a) . We have previously found a high degree of crossreactivity between absorbed lung-cancer antisera and lung-tumour substrates in an indirect immunofluorescence test (Newman et al., 1977b) . We now report the use of an established tumour cell line for the production of cross-reacting anti-tumour sera. The antiserum described here has a high titre of activity against CEA, and after removal of this, the absorbed antiserum reacts with the 4 major histological types of lung tumour in an indirect immunofluorescence test.
MATERIALS AND METHODS
The cell line (OCCI) On Day 37, 500 ml of blood (B13) wvas taken.
Test bleeds.-20 ml pre-immunization blood samples were obtained and test bleeds taken at weekly intervals throughout the schedule. All sera were heat-inactivated (56°C for 30 min).
Serum absorption and y-globulin precipitation.-B6 and B13 were absorbed x 3 with washed human cadaver spleens using 150 g/ 190 ml serum. The sera were then fractionated by double ammonium sulphate precipitation (Newman et al., 1977a) . Antibodies to CEA were removed from an aliquot of B6 serum by absorption of a 1/1000 dilution with pure CEA by Dr Eadie Heyderman, at the Chester Beattie Research Institute. After absorption, the serum was negative when tested for anti-CEA by radioimmunoassay, and failed to show any fixation to a CEAcontaining colonic carcinoma in an immunoperoxidase assay.
Monitoring of inmnunizations and absorptions.
-All serum samples were tested for haemolytic and haemagglutinating activity against normal human red cells. Micro-platelet complement-fixations tests were performed by the method of Colombani et al. (1972) and micro-lymphocytotoxic tests by a modification of the method of Amos et al. (1969) .
The serum-protein patterns of B6 and B13 before and after absorption, and after Ig precipitation, were determined by agarosegel electrophoresis as described by Johansson (1972) .
Immunofiuorescence staining.
Tissue blocks taken from fresh surgical specimens were snap-frozen and then stored in liquid N2. Wrells were prepared by placing 8 drops of glycerol on to a 1" x 3" slide and spraying with "Fluoroglide" PTFE (Fisons). The glycerol drops were then washed off, leaving, wells. Tissue blocks were cut into 5 yum sections on a cryostat and placed either in the wells or on ordinary 1" x 3" slides for histological examination. All sections were air dried with warm air for 20 min and cold air for 10 min. Those for histology were stained using a routine haematoxylin and eosin method. Serial dilutions of test antisera (goat antihuman), absorbed sera or Igs were applied to the wells. After 20 min incubation at room temperature (all subsequent procedures were carried out at room temperature) slides were washed for 10-20 min in a PBS bath with a magnetic stirrer.
Fluorescein-isothiocyanate-conjugated rabbit anti-goat y-globulin (Kallestad) was diluted with a 1/200 dilution of rhodamine as a counterstain. The dilution of conjugate used was determined previously by titration with goat Ig, and in this study was 1/10. Before use, diluted conjugate was centrifuged at 3000 g for 5 min to remove aggregates. The supernatant was added to the sections followed by a 20 min incubation. Sections wvere washed for 10 min in a PBS bath, mounted in glycerol, a coverslip applied and they were then examined for fluorescence. In control wells, sections were incubated with one of the following instead of the test serum or Ig: (1) PBS: a negative control to ensure no nonspecific localization of conjugate.
(2) Normal goat serum: a positive fluorescence control to ensure that the conjugate reacts with goat globulin. (3) igs from sera raised to a mycosis fungoides tumour and to gastric cancers, absorbed and fractionated in the same way as the anti-oatcell sera: the specificity controls.
Microscopy.-Microscopy was carried out with a Reichert Zetopan microscope using transmitted light from a mercury-vapour lamp (HBO 200) . The system incorporates a fluorescein-isothiocyanate blue exciter filter, widefield immersion darkground condenser, wide aperture x 40 objective and blue barrier filter. When UV light was used to observe sections, UV exciter and barrier filters were used. Photographs of representative sections were taken with a Vickers camera and photometer using Agfachrome 50L professional film.
Assay of anti-CEA activity.-Activity was measured by radioimmunoassay by a modification of the method of Egan et al. (1972) . To determine the CEA-binding capacity of the serum, serial dilutions were reacted with MRC standard125 I-labelled CEA. Antigen-antibody complexes formed were collected by polyethyleneglycol precipitation. Appropriate serum dilutions were then compared with standard anti-CEA sera in inhibition tests using competing unlabelled CEA.
RESULTS

Immanization procedure
The reactivity of the xenogeneic antisera against normal human cells, throughout the course of immunization, is illustrated in Fig. 1 (Fig. 3) . The culture medium from OCCI cells, when tested in a CEA assay, gave no detectable level of secreted CEA. However, these results demonstrate clearly that the antiserum raised to OCCI cells, has a high titre of anti-CEA activity.
After removal of anti-CEA antibodies from the B6 absorbed serum at a dilution of 1: 1000, there was no significant fall in the surgically resected specimens, of an antigen not present on normal spleen cells and not cross-reacting with CEA. Although the interpretation of indirect immunofluorescence is sometimes difficult, and the use of positive and negative controls mandatory, we have not seen any comparable levels or types of cell-membrane fluorescence with absorbed Igs prepared against other types of tumour or against normal tissues. Cytoplasmic fluorescence is usually present, at lower titres, against most cells including tumour cells. Cellmembrane fluorescence seen at much lower titres against some normal tissues was expected, as total absorption of all antinormal antibodies in the screening tests against red cells, lymphocytes and platelets had not been achieved. In other experiments we have used extracts of other tissues, including kidney, bronchus and normal lung for absorption but have failed to remove the antibody to the tumour-cell-membrane antigens, even when the antiserum has no anti-normal activity against the tissue used for absorption. Thus, although it is possible that a dense expression of "normal" antigen on the membrane of the tumour cell might localise, in very high concentration, an anti-normal antibody, it seems more likely that the anti-tumour antibody has been raised against an antigen immunologically specific to the lung-cancer cells removed at operation and not lost during in vitro culture of an established cell line in the laboratory. In this context it would be interesting to delineate the relationship of this antigen to the inhibitory, tumourassociated and Herpes simplex virus antigens described by Hollinshead and Stewart (1977) .
